Gene Patents Limited by Supreme Court

Gene Patents Limited by Supreme Court Play

June 13 (Bloomberg) -- The U.S. Supreme Court restricted the ability of companies to patent human genetic sequences, issuing a mixed ruling in a case that raised questions about thousands of biotechnology, agricultural and drug patents. Olivia Sterns reports on Bloomberg Television's "Bottom Line." (Source: Bloomberg)

  • On Air Now

    Bloomberg West Special: "The Alibaba Story" Watch Now

  • Next

    Bloomberg West

blog comments powered by Disqus